InvestorsHub Logo
Followers 4
Posts 332
Boards Moderated 0
Alias Born 06/03/2009

Re: garde54 post# 12828

Monday, 09/21/2009 2:57:06 PM

Monday, September 21, 2009 2:57:06 PM

Post# of 18532
On Picksheets filing "Management Discussion and Analysis- H1N1 Vaccines and Hard to Treat Diseases (HTDS)" received 09212009. http://www.pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=24471

What in the hell does this mean
The Clinical trials are Approved through its close partner in China, the license will be granted very soon and productions to start shortly, has inquiries from other countries, significant deal expect October and November

Hulan Bilogical Engineering does not seem to be the partner through NCPC as they state the follow There are at least three other approved H1N1 flu vaccine companies in China: the
Shanghai Institute of Biological Sciences, Hualan Biological Engineering and Hard to Treat Diseases.